Intra-Cellular Therapies, Inc.

GEODE CAPITAL MANAGEMENT, LLC

Report date

3/31/2025

Quarter

2025 Q1

Filed

5/13/2025

Shares

1,831,951

Value ($000)

241,741

Weight

0.0%

2014 Q1 - 2025 Q1 (23 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q1	5/13/2025	241,741	0.0%	1,831,951	3/31/2025
2024 Q4	2/12/2025	143,434	0.0%	1,716,829	12/31/2024
2024 Q3	11/12/2024	125,029	0.0%	1,708,301	9/30/2024
2024 Q2	8/9/2024	115,516	0.0%	1,686,173	6/30/2024
2024 Q1	5/13/2024	142,938	0.0%	2,065,298	3/31/2024
2023 Q4	2/13/2024	143,384	0.0%	2,001,791	12/31/2023
2023 Q3	11/13/2023	99,557	0.0%	1,911,022	9/30/2023
2023 Q2	8/11/2023	116,303	0.0%	1,836,757	6/30/2023
2023 Q1	5/15/2023	94,709	0.0%	1,749,018	3/31/2023
2022 Q4	2/13/2023	88,452	0.0%	1,671,437	12/31/2022
2022 Q3	11/14/2022	75,299	0.0%	1,618,310	9/30/2022
2022 Q2	8/12/2022	90,665	0.0%	1,588,399	6/30/2022
2022 Q1	5/13/2022	90,007	0.0%	1,470,957	3/31/2022
2021 Q4	2/11/2022	67,299	0.0%	1,285,814	12/31/2021
2021 Q3	11/12/2021	47,447	0.0%	1,272,720	9/30/2021
2021 Q2	8/13/2021	51,155	0.0%	1,253,202	6/30/2021
2021 Q1	5/12/2021	40,537	0.0%	1,194,753	3/31/2021
2020 Q4	2/12/2021	35,234	0.0%	1,107,996	12/31/2020
2020 Q3	11/13/2020	25,746	0.0%	1,003,364	9/30/2020
2020 Q2	8/13/2020	21,640	0.0%	843,024	6/30/2020
2020 Q1	5/14/2020	12,397	0.0%	806,602	3/31/2020
2019 Q4	2/13/2020	21,941	0.0%	639,498	12/31/2019
2014 Q1	5/14/2014	1,013	0.0%	55,775	3/31/2014